Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Effect of Video Viewing on Intravitreal Injection Experience

Impact of Procedural Video Viewing on Patients Undergoing Intravitreal Anti-VEGF Injections

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Study Objective The goal of this clinical trial is to evaluate whether viewing a procedural video can improve the patient experience and reduce the incidence and severity of subconjunctival hemorrhage in individuals undergoing intravitreal anti-VEGF injections. Key Research Questions 1. Can viewing the procedural video prior to treatment reduce the rate and/or area of subconjunctival hemorrhage? 2. Can the video improve the patient experience, specifically by reducing anxiety levels and increasing satisfaction with the treatment process? Study Design Participants will be randomly assigned to either an intervention group, who will watch an educational video explaining the injection procedure, or a control group, who will not view the video. All participants will complete the State-Trait Anxiety Inventory-State (STAI-S) questionnaire both before and after treatment to assess changes in anxiety levels.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients who are receiving their first intravitreal injection of anti-VEGF medication due to retinal diseases - Mentally competent, and able to communicate without barriers - Willing to voluntarily sign an willing to sign a consent form form. Who Should NOT Join This Trial: - History of previous eye surgery - Best-corrected visual acuity in the better eye worse than 0.3 - The target eye is complicated with neovascular glaucoma. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients who are receiving their first intravitreal injection of anti-VEGF medication due to retinal diseases * Mentally competent, and able to communicate without barriers * Willing to voluntarily sign an informed consent form. Exclusion Criteria: * History of previous eye surgery * Best-corrected visual acuity in the better eye worse than 0.3 * The target eye is complicated with neovascular glaucoma.

Treatments Being Tested

BEHAVIORAL

Procedure video viewing

Patients who have never had an intravitreal injection before will be randomly assigned to watch an educational video about the procedure prior to treatment.

Locations (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China